Pharmacologic management of asthma in childhood.
New drugs such as inhalable corticosteroids, disodium chromoglycate, and selective beta2 sympathomimetic agents, as well as new understanding of pathophysiologic mechanisms of older drugs, enable better pharmacologic management of the child with asthma. Emphasis is on educating patient and parents and on using doses calculated for weight of anhydrous theophylline equivalent as well as for beta agonists. Preventive environmental measures should always be used in conjunction with drug therapy.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000322:Adrenergic Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D004809:Ephedrine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans
D000305:Adrenal Cortex Hormones; D000322:Adrenergic Agonists; D000318:Adrenergic beta-Agonists; D005100:Expectorants; D006634:Histamine H1 Antagonists; D000628:Aminophylline; D004809:Ephedrine; D004837:Epinephrine